• 1
    Jossart GH, Clark OH. Well-differentiated thyroid cancer. Curr Probl Surg. 1994; 31: 9331012.
  • 2
    Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990; 10: 545576.
  • 3
    LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994; 4: 233236.
  • 4
    Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985; 55: 805828.
  • 5
    Tielens E, Sherman S, Hruban R, Landenson P. Follicular variant of papillary thyroid carcinoma. Cancer. 1994; 73: 424431.
  • 6
    [No authors listed]. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract. 2001; 7: 202220.
  • 7
    HedingerC, WilliamsED, SobinLH, editors. Histologic typing of thyroid tumours. In: Fleming ID, Cooper JS, Henson DE, et al. World Health Organization international histological classification of tumours, 2nd edition. Berlin: Springer-Verlag, 1988: 910.
  • 8
    American Joint Committee on Cancer. Thyroid gland. In: Manual for staging of cancer. 5th ed. Philadelphia: JB Lippincott, 1997: 4750.
  • 9
    Hundahl AS, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the US 1985–1995. Cancer. 1998; 83: 26382648.
  • 10
    Thyroid cancer: natural history, management strategies (surgery, XRT and RAI) and outcomes. 41st annual scientific meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Antonio, Texas, October 31, 1999.
  • 11
    Mazzeferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418428.
  • 12
    Gardet P, Parmentier C, Gerard-Marchant R. Differentiated cancers of thyroid: course after treatment with special reference to frequency and chronology of first relapse of 470 treated patients. Ann Radiol. 1977; 20: 831840.
  • 13
    Zidan J, Kassem S, Beny A, Kuten A. Prognostic factors and survival of patients with papillary carcinoma of thyroid. Reprinted from the 17th International Cancer Congress, Rio de Janeiro: Monduzzi editore. International Proceedings Division, 1998: 567570.
  • 14
    Zidan J, Kassem S, Kuten A. Follicular carcinoma of the thyroid gland: prognostic factors, treatment and survival. Am J Clin Oncol (CCT). 2000; 23: 15.
  • 15
    Hannequin P, Liehan JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer. 1986; 58: 17491755.
  • 16
    Schelfhout LJ, Creutzberg CL, Hamming JF, et al. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol. 1988; 24: 331337.
  • 17
    Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Ann. 1985; 20: 144.
  • 18
    Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988; 14: 10631075.
  • 19
    Maxon HR III, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med. 1992; 33: 11321136.